Journal
NATURE REVIEWS CLINICAL ONCOLOGY
Volume 9, Issue 6, Pages 312-313Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrclinonc.2012.76
Keywords
-
Categories
Ask authors/readers for more resources
The benefit of salvage chemotherapy in gastric cancer refractory to first-line platinum and fluoropyrimidine therapy was previously unknown. A randomized multicentre study has shown that irinotecan or docetaxel administered as single agents improved survival compared with best supportive care alone. Hence, salvage chemotherapy is now a proven option in pretreated gastric cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available